
The 89-year-old monarch is receiving treatment for a bacterial infection in his blood while hospitalized in Oslo.
AI-generated summary
King Harald has reigned since 1991 and is Europe's oldest monarch. He has faced multiple health challenges recently, including the installation of a pacemaker and hospitalizations for infection.
The health of Norway's King Harald has "deteriorated" while in the hospital this weekend, the royal household said in a statement on Sunday.
Harald, 89, is being treated for haemolytic anaemia, a condition caused by the rapid destruction of red blood cells.
The disorder causes fatigue, weakness, shortness of breath and paleness.
"His Majesty the King's health deteriorated over the weekend. The King is receiving antibiotics for a bacterial infection in his blood, and has responded to this treatment," the palace said. His condition was stable, the statement added.
What else do we know about the health of Norway's king?
Harald was admitted on Monday to Oslo University Hospital because of fluid retention related to cortisone treatment he has been receiving. He was placed on sick leave for two weeks.
The king has also canceled a visit to the Trondelag region in central Norway on September 1 and 2, which fall after the two-week sick leave period.
Several relatives have visited him in hospital on Sunday, including his wife, Queen Sonja, their son Crown Prince Haakon, Haakon's wife Crown Princess Mette-Marit and the king's sister, according to the Verdens Gang newspaper.
Haakon has been acting as regent in his father's absence.
Harald's history of health issues
Harald, who ascended the throne in 1991, is the oldest reigning monarch in Europe.
The king has suffered from numerous health issues in recent years. He has had a pacemaker fitted and has been forced to scale back his official activities and responsibilities.
He was hospitalized with an infection and dehydration in February this year during a private trip with Queen Sonja in Tenerife.
Despite his health issues, he has said he will not abdicate, as he took a lifelong oath before parliament.
Norwegian royals' difficult year
Harald's health is the latest concern for the Norwegian royals, who have been marred by scandal this year.
His son Haakon's wife, Mette-Marit, has been in the headlines for her close ties with late US financier and convicted sex offender Jeffrey Epstein.
Her son from a previous marriage, Marius Borg Hoiby, was sentenced in June to four years in prison on two counts of rape.
Hoiby has appealed the verdict.
AI outlook — possibilities, not facts
Crown Prince Haakon will continue to act as regent during the King's absence.
Very likely · Within weeks

Gaza's healthcare system faces a silent collapse as displacement camps lack basic medical services. Medics report widespread chronic and infectious diseases among the homeless, exacerbated by the destruction of infrastructure and the limited operational capacity of UNRWA.

Rising drug prices and supply shortages in Iran are forcing patients to delay or abandon critical treatments. Economic instability, currency devaluation, and banking restrictions linked to sanctions have severely impacted access to essential medicines.

The Ebola outbreak in the DRC has reached 5,515 confirmed cases and 2,642 deaths. With 51 new cases in Ituri and North Kivu, the WHO and Pope Leo are urging increased international support to contain the virus, which now has a 48 percent fatality rate.

Lillian Smart, an eight-year-old from Ruston, Louisiana, has died after contracting the rare brain-eating amoeba Naegleria fowleri. Health officials believe the infection occurred while she was swimming in Lake Claiborne.
Medical experts have raised concerns regarding President Donald Trump's health following a 23-pound weight gain over three years. While the White House maintains the president remains sharp and energetic, doctors emphasize the need for dietary intervention to mitigate obesity risks.

Recent data suggests a potential decline in US obesity prevalence for the first time in over a decade, with experts pointing to the increased use of GLP-1 weight-loss medications like Ozempic and Wegovy as a possible, though unproven, contributing factor.